Citation Impact
Citing Papers
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
2005 Standout
Synthesis of carbocyclic nucleosides
1994
Fluorinated nucleosides: Synthesis and biological implication
2008
Crystal Structure of the HSV-1 Fc Receptor Bound to Fc Reveals a Mechanism for Antibody Bipolar Bridging
2006 StandoutNobel
Mechanisms of type-I- and type-II-interferon-mediated signalling
2005 Standout
The Human Cytomegalovirus US11 Gene Product Dislocates MHC Class I Heavy Chains from the Endoplasmic Reticulum to the Cytosol
1996 Standout
Analysis of the Protein-Coding Content of the Sequence of Human Cytomegalovirus Strain AD169
1990 Standout
Marine natural products
1990 Standout
Synthesis and Properties of Allenic Natural Products and Pharmaceuticals
2004 Standout
CRISPR-Cas9 Circular Permutants as Programmable Scaffolds for Genome Modification
2019 StandoutNobel
Molecular dynamics of protein complexes from four-dimensional cryo-electron microscopy
2004
Hepatitis B virus infection
2009 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Disentangling conformational states of macromolecules in 3D-EM through likelihood optimization
2006 StandoutNobel
X-ray Crystallographic Studies of a Series of Penicillin-Derived Asymmetric Inhibitors of HIV-1 Protease
1994
On the antitumor properties of novel cyclometalated benzimidazole Ru(ii), Ir(iii) and Rh(iii) complexes
2013
Ab Initio Modeling of the Herpesvirus VP26 Core Domain Assessed by CryoEM Density
2006 StandoutNobel
Sec6l-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction
1996 StandoutNature
Designing antimicrobial peptides: form follows function
2011 Standout
Anchor extension: a structure-guided approach to design cyclic peptides targeting enzyme active sites
2021 StandoutNobel
The C. elegans genome sequencing project: a beginning
1992 StandoutNatureNobel
Three-dimensional structure of human cytomegalovirus protease
1996 Nature
Herpes simplex virus type 1 mutants for the origin-binding protein induce DNA amplification in the absence of viral replication
1990 StandoutNobel
Chronic hepatitis B
2007 Standout
Chronic hepatitis B: Update 2009 #
2009 Standout
Peginterferon α‐2a (40 kDa): an advance in the treatment of hepatitis B e antigen‐positive chronic hepatitis B
2003
New first and second generation inhibitors of human immunodeficiency virus-1 integrase
2011
Emtricitabine, a New Antiretroviral Agent with Activity against HIV and Hepatitis B Virus
2005
Design of activated serine–containing catalytic triads with atomic-level accuracy
2014 StandoutNobel
Nucleation and growth phases in the polymerization of coat and scaffolding subunits into icosahedral procapsid shells
1993
The chemistry and biology of organic guanidine derivatives
2008
Asymmetric synthesis and biological evaluation of .beta.-L-(2R,5S)- and .alpha.-L-(2R,5R)-1,3-oxathiolane-pyrimidine and -purine nucleosides as potential anti-HIV agents
1993
Primate cytomegalovirus assembly: Evidence that DNA packaging occurs subsequent to B capsid assembly
1988
Structure of the Human Cytomegalovirus Protease Catalytic Domain Reveals a Novel Serine Protease Fold and Catalytic Triad
1996
Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells
1992 StandoutNobel
The Complete DNA Sequence of the Long Unique Region in the Genome of Herpes Simplex Virus Type 1
1988 Standout
Nucleotide sequence of the herpes simplex virus type 2 gene encoding the protease and capsid protein ICP35
1995
Asymmetric 1,3-Dipolar Cycloaddition Reactions
1998 Standout
Physical mapping and nucleotide sequence of a herpes simplex virus type 1 gene required for capsid assembly
1989
Isolation of human cytomegalovirus intranuclear capsids, characterization of their protein constituents, and demonstration that the B-capsid assembly protein is also abundant in noninfectious enveloped particles
1985
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
1996 Standout
Fluorine in medicinal chemistry
2007 Standout
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
1997 Standout
Herpes simplex virus type 1 protease expressed in Escherichia coli exhibits autoprocessing and specific cleavage of the ICP35 assembly protein
1992
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Crystal Structures of Protein-Bound Cyclic Peptides
2019
[2+3]-cycloadditions of enantiomerically pure oxazoline-N-oxides1:A short stereoselective synthesis of (+)-carbovir
1995
Reactions of electron-rich indoles with triflic anhydride
2009
Structure activity studies on pseudo-symmetrical HIV-1 protease inhibitors
1993
Characterisation of a herpes simplex virus type 1 mutant which has a temperature-sensitive defect in penetration of cells and assembly of capsids
1984
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Antiviral therapy for human immunodeficiency virus infections
1995
Antiviral Treatment of Chronic Hepatitis B Virus (HBV) Infections
2010
Bis- and Trisindolylmethanes (BIMs and TIMs)
2009 Standout
Molecular and Biotechnological Aspects of Microbial Proteases
1998 Standout
Solid-Phase Synthesis of N-Substituted Glycine Oligomers (α‑Peptoids) and Derivatives
2010
The alpha sequence of the cytomegalovirus genome functions as a cleavage/packaging signal for herpes simplex virus defective genomes
1985
Inhibition of Human Cytomegalovirus Protease by Monocyclic β-Lactam Derivatives: Kinetic Characterization Using a Fluorescent Probe
1999
Characterization of phosphoproteins and protein kinase activity of virions, noninfectious enveloped particles, and dense bodies of human cytomegalovirus
1986
Comprehensive Review in Current Developments of Imidazole-Based Medicinal Chemistry
2013
Heterocycles in drugs and drug discovery
2012
Chronic Hepatitis B Virus Infection: Treatment Strategies for the Next Millennium
2000
Proteolytic activity of human cytomegalovirus UL80 protease cleavage site mutants
1994
Synthesis and biological evaluation of a series of HIV-1 protease inhibitors
1993
Transport, metabolism and elimination mechanisms of anti-HIV agents
1999
Primate cytomegalovirus assembly protein: genome location and nucleotide sequence
1989
Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro
1997
Identification of the sites of interaction between the scaffold and outer shell in herpes simplex virus-1 capsids by difference electron imaging
1998
Cloning, expression and characterization of the proteinase from human herpesvirus 6
1996
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Hsv‐ and chemical carcinogen‐induced amplification of sv40 dna sequences in transformed cells is cell‐line‐dependent
1985 StandoutNobel
Structure of a Covalently Trapped Catalytic Complex of HIV-1 Reverse Transcriptase: Implications for Drug Resistance
1998 StandoutScience
New Cytochalasins from the Marine‐Derived Fungus Xylaria sp. SCSIO 156
2011
Merobatzelladines A and B, Anti-Infective Tricyclic Guanidines from a Marine Sponge Monanchora sp.
2009 StandoutNobel
Spicochalasin A and New Aspochalasins from the Marine‐Derived Fungus Spicaria elegans
2009
A subset of herpes simplex virus replication genes induces DNA amplification within the host cell genome
1989 StandoutNobel
The promoter, transcriptional unit, and coding sequence of herpes simplex virus 1 family 35 proteins are contained within and in frame with the UL26 open reading frame
1991
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
Protein epitope mimetics as anti-infectives
2011
Phylogenetic Identification of Fungi Isolated from the Marine Sponge Tethya aurantium and Identification of Their Secondary Metabolites
2011
Herpes Simplex Virus Type 1 Capsids Transit by the trans -Golgi Network, Where Viral Glycoproteins Accumulate Independently of Capsid Egress
2005
Plant Products as Antimicrobial Agents
1999 Standout
Engineering Biomolecular Self‐Assembly at Solid–Liquid Interfaces
2020 StandoutNobel
Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus
1995
An analysis of vertebrate mRNA sequences: intimations of translational control.
1991 Standout
Antiviral Nucleoside Analogues with Axial Chirality
1997
A Field Guide to Foldamers
2001 Standout
ITERATIVE PROTEIN STRUCTURE-BASED DRUG DESIGN AND SYNTHESIS OF HIV PROTEASE INHIBITORS
1995
Structural and Pharmacological Effects of Ring-Closing Metathesis in Peptides
2010
Supramolecular Helical Systems: Helical Assemblies of Small Molecules, Foldamers, and Polymers with Chiral Amplification and Their Functions
2016 Standout
The protease of herpes simplex virus type 1 is essential for functional capsid formation and viral growth
1994
Recent advances in the synthesis of fluorinated nucleosides
2009
Assembly of herpes simplex virus (HSV) intermediate capsids in insect cells infected with recombinant baculoviruses expressing HSV capsid proteins
1994
Structural basis for scaffolding-mediated assembly and maturation of a dsDNA virus
2011 StandoutNobel
Diversity Oriented Clicking (DOC): Divergent Synthesis of SuFExable Pharmacophores from 2‐Substituted‐Alkynyl‐1‐Sulfonyl Fluoride (SASF) Hubs
2020 StandoutNobel
Viral Proteases
2002
Transition-Metal-Catalyzed Reactions in Heterocyclic Synthesis
2004 Standout
Metal–Organic Frameworks in Biomedicine
2011 Standout
Physical Mapping of Temperature-sensitive Mutations of Herpes Simplex Virus Type 1 Using Cloned Restriction Endonuclease Fragments
1983
Ring closure metathesis of indole 2-carboxylic acid allylamide derivatives
2002
Inhibition of human cytomegalovirus protease by benzoxazinones and evidence of antiviral activity in cell culture
1997
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Single-Step Kinetics of HIV-1 Reverse Transcriptase Mutants Responsible for Virus Resistance to Nucleoside Inhibitors Zidovudine and 3-TC
1997
Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus
1983
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
2011 Standout
Works of Jonathan A. Coates being referenced
Fluorocarbocyclic nucleosides: synthesis and antiviral activity of 2'- and 6'-fluorocarbocyclic 2'-deoxyguanosines
1991
Design of a series of bicyclic HIV-1 integrase inhibitors. Part 1: Selection of the scaffold
2010
Synthesis and antibacterial studies of binaphthyl-based tripeptoids. Part 1
2010
Crystal Structures of Novel Allosteric Peptide Inhibitors of HIV Integrase Identify New Interactions at the LEDGF Binding Site
2011
Synthesis and antibacterial studies of binaphthyl-based tripeptoids. Part 2
2010
A Novel Aspochalasin with HIV-1 Integrase Inhibitory Activity from Aspergillus flavipes
2005
Fluoro carbocyclic nucleosides: synthesis and antiviral activity of 2'- and 6'-fluoro carbocyclic pyrimidine nucleosides including carbocyclic 1-(2-deoxy-2-fluoro-.beta.-D-arabinofuranosyl)-5-methyluracil and carbocyclic 1-(2-deoxy-2-fluoro-.beta.-D-arabinofuranosyl)-5-iodouracil
1990
Design of a series of bicyclic HIV-1 integrase inhibitors. Part 2: Azoles: Effective metal chelators
2010
Discovery of potent HIV integrase inhibitors active against raltegravir resistant viruses
2010
Cellular metabolism of (−) enantiomeric 2′-deoxy-3′-thiacytidine
1992
Binaphthyl scaffolded peptoids via ring-closing metathesis reactions and their anti-bacterial activities
2009
Penicillin derived C2-symmetric dimers as novel inhibitors of HIV-1 proteinase
1992
Chiral carbocylic nucleosides: The synthesis and antiviral activity of 4′-hydroxy and 4′-fluorocarbocyclic - 2′- deoxyguanosines
1993
New cyclic peptides via ring-closing metathesis reactions and their anti-bacterial activities
2008
A novel class of 1,3-oxathiolane nucleoside analogues having potent anti-HIV activity
1993
The Synthesis of a Novel Carbazole-linked Cyclic Peptoid with Antibacterial Activity
2002
Carbovir: the (—) enantiomer is a potent and selective antiviral agent against human immunodeficiency virus in vitro
1991
The synthesis of a novel binaphthyl-based cyclic peptoid with anti-bacterial activityElectronic supplementary information (ESI) available: ESMS data. See http://www.rsc.org/suppdata/nj/b2/b205894b/
2002
Identification and Characterization of a Herpes Simplex Virus Gene Product Required for Encapsidation of Virus DNA
1983